Subscribe to news
Latest news

investorpress clippingsvideopodcastperriman
Webull: 'Biotech Sector' webinar by Damien PerrimanJune 30, 2026
biofuelmedicinepress clippingsscience
Biomass Magazine: Why Use Living Cells? NLR Is Making Chemicals With Enzymes AloneJune 29, 2026
press clippingscannabinoids
Bionity.com: EXOZ awarded $2M NIH grant to advance cannabinoid analogues for drug discoveryJune 26, 2026
press clippingscannabinoids
PRISM MarketView: NIH Cash Fuels eXoZymes’ Push Into Next‑Gen CannabinoidsJune 25, 2026
nutraceuticalspress clippingspodcastperrimanNCT
Ladder17 podcast: How eXoZymes is Scaling as a Public CompanyJune 25, 2026